88
6
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1889 |
MCL0020
MCL 0020 |
Melanocortin Receptor | GPCR/G Protein; Neuroscience |
MCL0020 是一种有效的选择性黑素皮质素MC4受体拮抗剂,IC50为 11.63 nM。它剂量依赖性减轻束缚应激诱发的厌食症,在体内表现出抗焦虑样活性。 | |||
T12041 |
MIM1
Inhibitor of Mcl-1 |
BCL | Apoptosis |
MIM1 (Inhibitor of Mcl-1) 是一种骨髓细胞因子 1 抑制剂。 | |||
T40230 |
Mcl-1 inhibitor 6
|
||
Mcl-1 inhibitor 6 is a potent, orally active chemical compound that selectively inhibits the myeloid cell leukemia 1 (Mcl-1) protein, with a high affinity (K d = 0.23 nM) and binding activity (K i = 0.02 μM). This compound exhibits exceptional selectivity over other members of the Bcl-2 family, including Bcl-2, Bcl2A1, Bcl-xL, and Bcl-w (K d >10 μM). Notably, Mcl-1 inhibitor 6 demonstrates strong antitumor activity. | |||
T27986 |
MCL0129
MCL-0129,MCL 0129 |
||
MCL0129, a selective and non-peptidergic melanocortin 4 (MC4) receptor antagonist, is a potential treatment for cachexia. | |||
T11972 | Mcl-1 inhibitor 3 | BCL | Apoptosis |
Mcl-1 inhibitor 3 shows good pharmacokinetic properties and excellent in vivo efficacy without toxicity.Mcl-1 inhibitor 3 is a highly potent and orally activate macrocyclic Mcl-1 inhibitor (Ki= 0.061 nM; IC50=19 nM in an OPM-2 cell viability assay). | |||
T11967 |
Mcl-1 antagonist 1
|
Others | Others |
Mcl-1 antagonist 1 is a Mcl-1 protein antagonist. | |||
T11969 |
MCL-1/BCL-2-IN-2
|
Others | Others |
MCL-1/BCL-2-IN-2 is a potent and selective Bcl-2 and Mcl-1 dual inhibitor. | |||
T11971 |
MCL-1/BCL-2-IN-4
|
Others | Others |
MCL-1/BCL-2-IN-4 is a selective and potent Mcl-1 and Bcl-2 dual inhibitor. | |||
T27996 |
MDK-3298
Mcl-1 Inhibitor-5,Mcl-1 Inhibitor 5,MDK3298,Mcl-1 Inhibitor5 |
||
MDK-3298 is a reversible covalent inhibitor of Mcl-1, a target of protein-protein interaction (PPI). | |||
T11970 |
MCL-1/BCL-2-IN-3
|
Others | Others |
MCL-1/BCL-2-IN-3 is a selective and potent Mcl-1 and Bcl-2 dual inhibitor with IC50s of 5.95 and 4.78 μM, respectiely. | |||
T11968 | MCL-1/BCL-2-IN-1 | BCL | Apoptosis |
MCL-1/BCL-2-IN-2 (Compound Nap-1) 是一种有效的选择性 Mcl-1和 Bcl-2双重抑制剂,IC50分别为 4.45 和 3.18 μM。 | |||
T27997 |
MDK-3345
MDK 3345,Mcl-1 Inhibitor11,Mcl-1 Inhibitor 11,Mcl-1 Inhibitor-11 |
||
MDK-3345 is a reversible covalent inhibitor for Mcl-1. | |||
T79242 |
Mcl-1 inhibitor 16
|
||
Mcl-1 inhibitor16 (Compound 9)为基于铂的线粒体靶向性Mcl-1抑制剂。该化合物通过诱导Bax/Bak依赖的细胞凋亡(apoptosis),展现出对癌细胞的作用,可以单独使用或与ABT-199联合应用,表现出抗肿瘤活性。 | |||
T79036 | Mcl-1 inhibitor 13 | ||
Mcl-1 inhibitor13 (Example 9),一种MCL-1抑制剂(Ki: 8.2 nM),主要用于癌症相关研究。 | |||
T75143 | Mcl-1 inhibitor 12 | ||
Mcl-1 inhibitor12 (Example 10) 作为一种高效的MCL-1抑制剂 (Ki: 0.22 nM),主要应用于癌症研究领域。 | |||
T72610 | Mcl-1 inhibitor 9 | ||
Mcl-1 inhibitor9 (example 2) 是一种 myeloid cell leukemia 1(Mcl-1) 抑制剂,IC50值为 0.21889 nM,其具有抗肿瘤活性。 | |||
T79215 |
Mcl-1 inhibitor 14
|
||
Mcl-1 inhibitor14 (Compound (Ra)-10)作为一种优异的髓系细胞白血病-1 (MCL-1) 抑制剂,其Ki值为0.018 nM,主要应用于抗癌研究领域。 | |||
T79216 |
Mcl-1 inhibitor 15
|
||
Mcl-1 inhibitor15 (Compound (Ra)-15),作为一种高效的Mcl-1抑制剂(Ki: 0.02 nM),主要应用于癌症的研究领域。 | |||
T62249 | Bcl-2/Mcl-1-IN-1 | ||
Bcl-2/Mcl-1-IN-1 是一种 Bcl-2 (Ki: 4.53 μM) 和 Mcl-1 (Ki: 1.19 μM) 抑制剂。Bcl-2/Mcl-1-IN-1 能够用于研究癌症。 | |||
T62443 |
Bcl-2/Mcl-1-IN-2
|
||
Bcl-2/Mcl-1-IN-2 是一种 Bcl-2 (Ki: 4.70 μM) 和 Mcl-1 (Ki: 0.88 μM) 抑制剂。Bcl-2/Mcl-1-IN-2 能够用于研究癌症。 | |||
T62941 | Bcl-2/Mcl-1-IN-3 | ||
Bcl-2/Mcl-1-IN-3 是一种 Bcl-2/Mcl-1 抑制剂,作用于 Mcl-1 (Ki: 0.14 μM) 和 Bcl-2 (Ki: 0.23 μM),能够用于研究癌症。 | |||
T10096L |
Voruciclib
|
CDK | Cell Cycle/Checkpoint |
Voruciclib 是一种具有口服活性和选择性 CDK 抑制剂,Ki 为 0.626 nM-9.1 nM。它在多种弥漫性大 B 细胞淋巴瘤模型中抑制 MCL-1 的表达。它有效阻断 MCL-1 的转录调节子 CDK9。 | |||
T18487 |
NH2-C6-NH-Boc
|
Others; PROTAC Linker | Others; PROTAC |
NH2-C6-NH-Boc 是一种属于 alkyl/ether 类的 PROTAC linker ,是基于 PROTAC 技术的 Mcl-1 抑制剂。 | |||
T16156 |
MT 63-78
|
Apoptosis; AMPK; mTOR | Apoptosis; Chromatin/Epigenetic; PI3K/Akt/mTOR signaling |
MT 63-78 是一种有效的直接AMPK 激活剂,EC50为 25 μM。它诱导细胞有丝分裂阻滞和细胞凋亡,通过抑制脂肪生成和mTORC1途径来阻止前列腺癌的生长,具有抗肿瘤作用。 | |||
T16027 |
Mcl1-IN-1
|
Others | Others |
Mcl1-IN-1 is a myeloid cell factor 1 inhibitor (IC50=2.4 µM). | |||
T68398 |
MI-223
|
||
MI-223 is an inhibitor of Mcl-1-stimulated homologous recombination (HR) DNA repair, which leads to sensitization of cancer cells to hydroxyurea- or olaparib-induced DNA replication stress. | |||
T11973 | Mcl1-IN-11 | BCL | Apoptosis |
Mcl1-IN-11 (Compound G) is a selective Mcl-1 inhibitor, less potent at Bcl-2, with Kis of 0.06 and 4.2 μM, respectively. | |||
T11977 | Mcl1-IN-9 | BCL | Apoptosis |
Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM. | |||
T11974 | Mcl1-IN-12 | BCL | Apoptosis |
Mcl1-IN-12 has anti-tumor activity.It is a selective Mcl-1 inhibitor, less potent at Bcl-2, with Kis of 0.29 and 3.1 μM, respectively. | |||
T16029 |
Mcl1-IN-3
|
Others | Others |
Mcl1-IN-3 is an Mcl1 inhibitor. It has an IC50 and Ki of 0.67 and 0.13 μM, respectively. | |||
T16028 |
IMB-XH1
Mcl1-IN-2,7-[(2-吡啶基氨基)-2-噻吩基甲基]-8-喹啉醇 |
BCL; Antibacterial | Apoptosis; Microbiology/Virology |
IMB-XH1 (Mcl1-IN-2) 是一种骨髓细胞因子 1 抑制剂。它也是非竞争性的 Delhi metallo-β-lactamase(NDM-1) 抑制剂。它对金属 β-内酰胺酶 NDM-1,IMP-4,ImiS 和 L1 的 IC50值分别为 0.4637 μM,3.980 μM,0.2287 μM 和 1.158 μM。 | |||
T16030 | Mcl1-IN-8 | Others | Others |
Mcl1-IN-8 is an Mcl-1-PUMA interface inhibitor (Ki: 0.3 μM). In cancer cells, Mcl1-IN-8 shows dual activity on reducing PUMA-dependent apoptosis while deactivating Mcl-1-mediated anti-apoptosis. | |||
T11976 | Mcl1-IN-4 | Others | Others |
Mcl1-IN-4 is an inhibitor of Mcl1 ( IC50:0.2 μM). | |||
T24436 |
Mcl1-IN-26
|
||
Mcl1-IN-26 is an effective and selective myeloid cell leukemia 1 inhibitor. | |||
T2558 |
Cladribine
2-chlorodeoxyadenosine,克拉屈滨,2-Chloro-2′-deoxyadenosine,CldAdo,2CdA |
Apoptosis; Adenosine deaminase | Apoptosis; Metabolism |
Cladribine (2CdA) 是一种嘌呤核苷类似物,是具有口服活性的腺苷脱氨酶抑制剂。它能作为 DNA 合成的抑制剂,可阻断受损 DNA 的修复。它可抑制 DNA 甲基化,具有抗淋巴瘤活性,可研究血液恶性肿瘤和多发性硬化。 | |||
T11975 |
PROTAC Mcl1 degrader-1
|
BCL | Apoptosis |
PROTAC Mcl1 degrader-1 induces the ubiquitination and proteasomal degradation of Mcl-1 by introducing the E3 ligase cereblon (CRBN)-binding ligand pomalidomide to Mcl-1 inhibitor S1-6 with μM-range affinity. PROTAC Mcl1 degrader-1, a proteolysis targeting chimera (PROTAC), is a potently and selectively Mcl-1 inhibitor with an IC50 of 0.78 μM. | |||
T19024 |
MCLA hydrochloride
|
Others | Others |
MCLA hydrochloride, a chemiluminescent compound, can be used to quantify aqueous concentrations of superoxide. | |||
T13657 |
dMCL1-2
|
Others | Others |
dMCL1-2 is a potent and selective myeloid leukemia 1 (MCL1) degrading agent based on PROTAC, which binds to MCL1 with a KD of 30 nM. dmcl-2 activates the apoptosis mechanism by degrading MCL1. | |||
T24812 |
SOMCL-863
|
||
SOMCL-863 is a selective and orally bioavailable c-Met inhibitor. It shows antitumor activity both in vitro and in vivo. | |||
T2632 |
A-1210477
|
Apoptosis; BCL | Apoptosis |
A-1210477 是一种选择性的MCL-1有效抑制剂,Ki 值为 0.45 nM。它特异性结合 MCL-1,并以 MCL-1 依赖性方式促进癌细胞凋亡。 | |||
T5108 |
ML311
|
BCL | Apoptosis |
ML311 是 Mcl-1/Bim 相互作用的一种选择性抑制剂。 | |||
T6034 |
UMI-77
UMI77,UMI 77 |
BCL | Apoptosis |
UMI-77是一种选择性的Mcl-1抑制剂,结合到Mcl-1的 BH3 结合沟,Ki 值为 490 nM,对 Bcl-2 家族的其他成员具有选择性。 | |||
T6281 |
TW-37
TW 37 |
BCL | Apoptosis |
TW-37 是重组 Bcl-2、Bcl-xL 和 Mcl-1 的非肽抑制剂,Ki 值分别为 0.26、0.29和1.11μM | |||
T17247 |
VU0661013
VU661013 |
BCL | Apoptosis |
VU0661013 是一种有效的选择性 MCL-1 抑制剂。 | |||
T5346 |
S63845
|
BCL | Apoptosis |
S63845 是一种选择性骨髓细胞白血病 1 抑制剂,结合人 MCL1的 Kd 值为 0.19 nM。 | |||
T6650 |
Sabutoclax
BI-97C1 |
BCL | Apoptosis |
Sabutoclax (BI-97C1) 是一种泛 Bcl-2 抑制剂,包括 Bcl-xL、Bcl-2、Mcl-1 和 Bfl-1,IC50 分别为 0.31 μM、0.32 μM、0.20 μM 和 0.62 μM。 | |||
T13639 |
Deferasirox (Fe3+ chelate)
|
Apoptosis | Apoptosis |
Deferasirox (Fe3+ chelate) 是一种可口服的铁螯合剂,具有潜在的抗癌活性,抑制 MCL-1 的抗凋亡活性,可用于研究铁超负荷。 | |||
T11944 |
Maritoclax
Marinopyrrole A |
BCL | Apoptosis |
Maritoclax (Marinopyrrole A) 是一种新型特异性 Mcl-1 抑制剂,IC50值为 10.1 μM,对 BCL-xl 的 IC50值 > 80 μM。 | |||
T6396 |
(R)-(-)-Gossypol acetic acid
(-)-Gossypol acetic acid,AT-101 (acetic acid),(R)-Gossypol acetic acid,AT101醋酸,AT101,AT101 acetate |
BCL; Autophagy | Apoptosis; Autophagy |
(R)-(-)-Gossypol acetic acid (AT101 acetate) 是天然产物 Gossypol 的左旋异构体,与 Bcl-2、Bcl-xL 和 Mcl-1 结合,Ki 为 0.32 μM、0.48 μM 和 0.18 μM。 | |||
T79404 |
A09-003
|
Apoptosis; BCL; CDK | Apoptosis; Cell Cycle/Checkpoint |
A09-003 是一种新型细胞周期蛋白依赖性激酶-9 CDK-9 抑制剂。A09-003 能够抑制多种白血病细胞系的增殖,抑制hi髓系细胞白血病序列-1蛋白增加。A09-003还能诱导细胞凋亡,降低 RNA 聚合酶 II 活性,降低 Mcl-1 表达。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6185 |
Gambogic Acid
藤黄酸,Beta-Guttiferrin,藤黄酸 A,Guttatic Acid,Guttic Acid |
BCL; Autophagy | Apoptosis; Autophagy |
Gambogic Acid (Guttic Acid) 是来自藤黄树的一种藤黄树脂,抑制 Bcl-XL、Bcl-2、Bcl-W、Bcl-B、Bfl-1和 Mcl-1,IC50分别为 1.47 μM、1.21 μM、2.02 μM、0.66 μM、1.06 μM 和 0.79 μM。 | |||
T2730 |
Gossypol (acetic acid)
(±)-Gossypol-acetic acid,Pogosin,AT101,醋酸棉酚,乙酸棉子酚,Gossypol acetic acid |
BCL | Apoptosis |
Gossypol acetic acid (AT101) 是一种从棉籽中分离出来的多酚天然产物,分别与 Bcl-xL 蛋白和 Bcl-2蛋白结合,Ki 值分别为 0.5-0.6 μM 和 0.2-0.3 mM。 | |||
T5688 |
Micheliolide
|
NOS; NF-κB; COX | Immunology/Inflammation; Neuroscience; NF-κB |
Micheliolide 是一种倍半萜内酯,能够抑制各种炎症反应。它能减弱高糖刺激的NF-κB 活化,IκBα的降解,和MCP-1,TGF-β1,FN 在鼠系膜细胞的表达。 | |||
T5668 |
Triacetylresveratrol
乙酰化白藜芦醇,三乙酰基白藜芦醇,Acetyl-trans-resveratrol |
BCL; NF-κB; STAT | Apoptosis; JAK/STAT signaling; NF-κB; Stem Cells |
Triacetylresveratrol (Acetyl-trans-resveratrol) 是 Resveratrol 的乙酰化类似物,可降低 STAT3和 NF-κB 磷酸化,具有抗癌作用。 | |||
T30969 |
Clitocine
|
Apoptosis; BCL | Apoptosis |
Clitocine 是一种来从蘑菇中提取的一种腺苷类似物,是一种有效的转录通读剂,是一种无义突变的抑制剂,具有抗癌活性,可诱导携带 p53 无义突变等位基因的细胞产生 p53 蛋白。Clitocine 通过促进 Mcl-1 降解来增强 TRAIL 介导的人结肠癌细胞凋亡。 | |||
T3824 |
Jaceosidin
|
Apoptosis; BCL; COX; UGT | Apoptosis; Immunology/Inflammation; Metabolism; Neuroscience |
Jaceosidin 是从毛莲蒿中得到的一种黄酮类天然产物,可激活Bax,下调 Mcl-1 和 c-FLIP 的表达,诱导癌细胞凋亡。它能够降低炎性因子水平,激活 NF-κB,抑制COX-2的表达,具有抗癌和抗炎作用。 |